Cyanotech (NASDAQ:CYAN) posted its quarterly earnings results on Tuesday. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The firm had revenue of $8.07 million for the quarter. Cyanotech had a negative return on equity of 22.50% and a negative net margin of 11.91%.
NASDAQ CYAN traded up $0.04 during trading hours on Wednesday, hitting $2.50. 109 shares of the stock were exchanged, compared to its average volume of 3,677. Cyanotech has a 12-month low of $2.42 and a 12-month high of $4.07. The stock has a 50-day moving average of $2.70. The company has a quick ratio of 0.35, a current ratio of 1.54 and a debt-to-equity ratio of 0.35.
Cyanotech Company Profile
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.